Get the SPI Wire

CDT Equity Inc.

NASDAQ:CDT
Annual Meeting

of Shareholders

MEETING DATE

08/28/2026
DEF 14A FILED
08/11/2026
PUBLISHED
08/11/2026 12:45 pm
TIME TO PUBLISH
08/13/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CDT · CUSIP 20678X502 · CLASS common stock, par value $0.0001 · CIK 0001896212

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

2
FOR
4
AGAINST
0
WITHHOLD
6
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Contested
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the board nominated five directors to serve one-year terms.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of the appointment of Carr, Riggs & Ingram, L.L.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Contested
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing discloses material weaknesses and a prior-period restatement in internal control over financial reporting.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of one or more amendments of the Company’s Second Amended and Restated Certificate of Incorporation to effect one or more reverse stock splits of our common stock, at a ratio ranging from any whole number between and including 1-for-2 and 1-for-100 and in the aggregate not more than 1-for-500, inclusive, as determined by the Company’s board of directors in its discretion, subject to the authority of the board of directors to abandon such amendments
other
Contested
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the reverse split could increase unissued authorized shares and have an anti-takeover effect.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve the issuance of shares of common stock, for purposes of Nasdaq Listing Rule 5635, pursuant to that certain senior secured convertible note and common stock purchase warrant issued to J.J. Astor & Co.
other
Contested
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the issuance will dilute current stockholders and reduce their ability to influence significant corporate decisions.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
To approve the issuance of up to an aggregate of 12,131,770 shares of Common Stock issuable upon exercise of certain pre-funded warrants to purchase the Company’s Common Stock, in accordance with Nasdaq Listing Rule 5635
other
Contested
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the issuance will dilute current stockholders and their ability to influence significant corporate decisions.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Approval of the adjournment or postponement of the Annual Meeting, if necessary, to continue to solicit votes for Proposals Nos. 1, 2, 3, 4, and 5
other
Contested
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states adjournment may be used if votes are insufficient to approve Proposals Nos. 1 through 5.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

ca3a77591cbea099c2816192c9634dd83315a616f23add0a5228aa85e5a8e601

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates